2YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| ISX 9 | ISX 9 | 832115-62-5 |
| 3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide | 3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 | 1232410-49-9 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide | GSK126 | 1346574-57-9 |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide | 化合物GSK503 | 1346572-63-1 |
| STF 31 | 4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 | 724741-75-7 |
| GLPG0634 | GLPG0634 | 1206101-20-3 |
| GLPG-0778 | SOLCITINIB | 1206163-45-2 |
| GSK2141795 | UPROSERTIB | 1047634-65-0 |
| 1H-Indole-3-ethanaMine, 6-fluoro-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]Methyl]- | LU AE58054 | 467459-31-0 |
| AZD3759 | AZD3759 | 1626387-80-1 |
| N-(2-(2-(4-chlorophenyl)thiazol-4-yl)ethyl)butyraMide | N-[2-[2-(4-氯苯基)-4-噻唑基]乙基]丁酰胺 | 932986-18-0 |
| guanoclor | 胍氯酚 | 5001-32-1 |
| IKK-16 | IKK-16 | 873225-46-8 |
| Pirmenol | Pirmenol | 68252-19-7 |
| GRA Ex-25 | N-[4-[[[反式-4-(1,1-二甲基乙基)环己基][[[4-(三氟甲氧基)苯基]氨基]羰基]氨基]甲基]苄基]-B-丙氨酸 | 307983-31-9 |
| Amg 517 | N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]氧基]-2-苯并噻唑基]乙酰胺 | 659730-32-2 |
| ML281 | ML281 | 1404437-62-2 |
| Ezutromid | 依珠曲米 | 945531-77-1 |
| BAY 59-3074 | BAY 59-3074 | 406205-74-1 |
| IKK epsilon-IN-1 | CS-1801 | 1292310-49-6 |
| GENZ-682452 | GENZ-682452 | 1401090-53-6 |
| INCB8761(PF-4136309) | INCB8761(PF-4136309) | 1341224-83-6 |
| GNF 5837 | GNF 5837 | 1033769-28-6 |
| SEA-0400 | 2-[4-[(2,5-二氟苯基)甲氧基]苯氧基]-5-乙氧基苯胺 | 223104-29-8 |
| NVP-BSK805 | NVP-BSK805 dihydrochloride | 1092499-93-8 |
| EAI-045 | EAI-045 | 1942114-09-1 |
| PLECONARIL | 普可那利 | 153168-05-9 |
| MELK-8a | MELK-8a | 1922153-17-0 |
| SGC2085 | SGC2085 | 1821908-48-8 |
| PFI-2 | PFI-2 | 1627676-59-8 |
| Tazemetostat (EPZ-6438) | EPZ-6438 | 1403254-99-8 |
| Bis(tricyclohexylphosphine)palladium(II) Dichloride | 二氯二(三环己基瞵)钯 | 29934-17-6 |
| 1,2-Bis(diphenylphosphino)ethane]dichloropalladium(II) | 1,2-二(二苯基膦基)乙烷二氯化钯(II) | 19978-61-1 |
| DICHLORO[1,3-BIS(DIPHENYLPHOSPHINO)PROPANE]PALLADIUM(II) | 1,3-双二苯基磷丙烷]氯化钯 | 59831-02-6 |
| 1,4-Bis(diphenylphosphino)butane-palladium(II) chloride | 1,4-双(二苯基膦丁烷)二氯化钯 | 29964-62-3 |
| SPhos Palladacycle Gen. 4 | 甲烷磺酸(2-二环己基膦-2',6'-二甲氧基联苯)(2'-甲胺基-1,1'-联苯-2-基)钯(II) | 1599466-87-1 |
| Palladacycle Gen. 3 | 甲磺酸(2-二环己基膦-2',6'-双(二甲氨基)-1,1'-联苯基)(2'-甲氨-1,1'-联苯-2-基)钯(II) | 1447963-73-6 |
| DavePhos-Pd-G3 | 甲磺酸[2-(二环己基膦基)-2' - (N,N-二甲基氨基)-1,1'-联苯](2'-氨基-1,1'-联苯-2-基)钯(II) | 1445085-87-9 |
| tBuXPhos Pd G1 | 氯[2-(二叔丁基膦基)-2',4',6'-三异丙基-1,1'-联苯基][2-(2-氨基乙基)苯基)]钯(II) | 1142811-12-8 |
| tBuXPhos-Pd-G3 | 甲烷磺酸(2-二叔丁基膦基-2',4',6'-三异丙基-1,1'-联苯基)(2'-氨基-1,1'-联苯-2-基)钯(II) | 1447963-75-8 |
| t-BuXphos Palladacycle Gen. 4 | 甲烷磺酸(2-二-叔丁基膦-2',4',6'-三异丙基联苯)(2'-甲胺基-1,1'-联苯-2-基)钯(II) | 1599466-89-3 |
| cataCXium A-Pd-G2 | 氯[(正丁基二(1-金刚烷基)膦)-2-(2-氨基联苯)]钯(II) | 1375477-29-4 |
| cataCXium A Pd G3 | 甲磺酸[正丁基二(1-金刚烷基)膦](2-氨基-1,1'-联苯-2-基)钯(II) | 1651823-59-4 |
| DICHLORO-[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOLIDINYLIDENE]-(3-CHLOROPYRIDYL)PALLADIUM(II) | PEPPSI(TM)-SIPR 催化剂 | 927706-57-8 |
| DICHLORO-[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLYLIDENE]-(3-CHLOROPYRIDYL)PALLADIUM(II) | 1,3-双(2,6-二异丙基苯)咪唑-2-叉](3-氯吡啶)二氯化钯 | 905459-27-0 |
| (R)-(+)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl]palladium(II) chloride | (R)-(+)-2,2'-双(二苯基膦)-1,1'-联萘]二氯化钯 | 115826-95-4 |
| (R)-(+)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL]PALLADIUM(II) CHLORIDE | (S)-(-)-2,2'-双(二苯基膦)-1,1'-联萘]二氯化钯 | 127593-28-6 |
| ALK/IGF1R inhibitor | AZD3463 | 1356962-20-3 |
| ARN-509 | 阿帕鲁胺 | 956104-40-8 |
| Orantinib (SU6668) | orantinib | 252916-29-3 |
| E-7820 | CS-2701 | 289483-69-8 |
| CEP-40783 | CEP-40783 | 1437321-24-8 |
| CPDD1211 | CPDD1211 | 1450881-50-6 |
| PF 573228 | 6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 | 869288-64-2 |
| 2-chloro-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine | 化合物5WKS | 1350752-07-6 |
| TG4-155 | TG4-155 | 1164462-05-8 |
| JNJ 26854165 | JNJ 26854165 | 875320-29-9 |
| TIRASEMTIV(CK-2017357) | TIRASEMTIV(CK-2017357) | 1005491-05-3 |
| CHZ868 | 1895895-38-1 | 1895895-38-1 |
| PF-562271 | N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 | 717907-75-0 |
| PF-3450074 | PF-3450074 | 1352879-65-2 |
| HG-14-10-04 | CS-1175 | 1356962-34-9 |
| ALK inhibitor 2 | 2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺 | 761438-38-4 |
| NVP-TAE684 | NVP-TAE684 | 761439-42-3 |
| NVP-BAW2881 | BAW2881 | 861875-60-7 |
| BLZ945 | BLZ945 | 953769-46-5 |
| Autophinib | 6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE | 1644443-47-9 |
| AST 487 | AST 487 | 630124-46-8 |
| OSI-930 | 3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺 | 728033-96-3 |
| t-BuBrettPhos Palladacycle Gen. 3 | 甲磺酸-2-(二叔丁基膦基)-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-联苯(2-氨基-1,1'-联苯-2-基)钯(II) | 1536473-72-9 |
| BrettPhos Pd G3 | 甲烷磺酸(2-二环己基膦)-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-联苯)(2'-氨基-1,1'-联苯-2-基)钯(II) | 1470372-59-8 |
| XantPhos-Pd-G2 | 氯[(4,5-双(二苯基膦)-9,9-二甲基氧杂蒽)-2-(2-氨基联苯)]钯(II) | 1375325-77-1 |
| XPhos Pd G4 | (SP-4-3)-[二环己基[2',4',6'-三(异丙基)[1,1'-联苯]-2-基]膦](甲烷磺酸)[2'-(甲基氨基)[1,1'-联苯]-2-基]钯 | 1599466-81-5 |
| 1,1'-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) | DPPF二氯化钯 | 72287-26-4 |
| Tris(dibenzylideneacetone)dipalladium-chloroform adduct | 三(二亚苄基丙酮)二钯-氯仿加合物 | 52522-40-4 |
| XPhos Pd G3 | 甲烷磺酸(2-二环己基膦基-2',4',6'-三-异丙基-1,1'-联苯基)(2'-氨基-1,1'-联苯-2-基)钯(II) | 1445085-55-1 |
| XPhos Pd G2 | 氯(2-二环己基膦基-2',4',6'-三异丙基-1,1'-联苯基)[2-(2'-氨基-1,1'-联苯)]钯(II) | 1310584-14-5 |
| Methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) | (2-二环己基膦-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-联苯)(2'-甲基氨基-1,1'-联苯-2-基)甲磺酸钯(II) | 1599466-83-7 |
| SPhos Pd G2 | 氯(2 - 二环己基膦基-2',6'-二甲氧基-1,1'-联苯基)(2'-氨基-1,1'-联苯-2 - 基)钯(II) | 1375325-64-6 |
| Methanesulfonato(tricyclohexylphosphine)(2'-aMino-1,1'-biphenyl-2-yl)palladiuM(II) dichloroMethane adduct | 烷磺酸(三环己基膦)(2-氨基-1,1'-联苯-2-基)钯(II) | 1445086-12-3 |
| Tris(dibenzylideneacetone)dipalladium-chloroform adduct | 三(二亚苄基丙酮)二钯 | 51364-51-3 |
| RuPhos Palladacycle Gen. 4 | 甲烷磺酸(2-二环己基膦基-2',4',6'-三-异丙基-1,1'-联苯基)(2'-氨基-1,1'-联苯-2-基)钯(II) | 1599466-85-9 |
| RuPhos Pd G3 | 甲磺酸(2-二环己基膦基-2',6'-二异丙氧基-1,1'-联苯基)(2-氨基-1,1'-联苯-2-基)钯(II) | 1445085-77-7 |
| Tris(dibenzylideneacetone)dipalladium-chloroform adduct | 三(二亚苄基茚丙酮)二钯(0) | 60748-47-2 |
| 1,1'-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex | 1,1'-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物 | 95464-05-4 |
| Bis(triphenylphosphine)palladium(II) chloride | 双三苯基磷二氯化钯 | 13965-03-2 |
| Tris(dibenzylideneacetone)dipalladium-chloroform adduct | 三(二亚苄基丙酮)二钯 | 52409-22-0 |
| SPhos Pd G3 | 甲磺酸(2-二环己基膦-2',6'-二甲氧基-1,1'-联苯基)(2'-氨基-1,1'-联苯-3-基)钯(II) | 1445085-82-4 |
| Xantphos Pd G3 | 甲烷磺酸[9,9-二甲基-4,5-双(二苯基膦)呫吨] [2'-氨基-1,1'-联苯]钯(II)二氯甲烷加合物 | 1445085-97-1 |
| XPhos Pd G1 | 氯(2-二环己基膦基-2',4',6'-三异丙基-1,1'-联苯)[2-(2-氨基乙基苯基)]钯(II) | 1028206-56-5 |
| Methanesulfonato[di-t-butyl(n-butyl)phosphine](2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane | 甲磺酸(三叔丁基膦基)(2'-氨基-1,1'-联苯-2-基)钯(II) | 1445086-17-8 |
| Chloro[(tricyclohexylphosphine)-2-(2'-aminobiphenyl)]palladium(II) | 氯[(三环己基膦)-2-(2-氨基联苯)]钯(II) | 1353658-81-7 |
| P(t-Bu)3 Pd G4 | 甲磺酸(三叔丁基膦基)(2'-甲氨基-1,1'-联苯-2-基)钯(II) | 1621274-11-0 |
| Chloro[(tri-tert-butylphosphine)-2-(2-aMinobiphenyl)]palladiuM(II) | 氯[(三-TERT-三丁基膦)-2-(2-氨基联苯)]钯(II) | 1375325-71-5 |
| SPhos Pd G1, Methyl t-Butyl Ether Adduct | 2 -二环己基膦- 2 6二甲氧基- 1 ,1 -联苯 | 1028206-58-7 |
| RuPhos Pd G1 Methyl t--Butyl Ether Adduct | 氯(2 -二环己膦基-2',6'-二I -丙氧基- 1,1'-联苯)[2- (2-氨基乙基苯基)]钯(Ⅱ),甲基叔丁基醚 | 1028206-60-1 |
| BrettPhosPalladacycle | 氯(2-二环己基膦基-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-联苯)[2-(2-氨基乙基苯基)]钯(II) | 1148148-01-9 |
| RuPhosPdG2 | [2'-(氨基)[1,1'-联苯]-2-基][[2',6'-二(1-甲基乙氧基)[1,1'-联苯]-2-基]二环己基膦]氯化钯 | 1375325-68-0 |
| Bis(dibenzylideneacetone)palladium | 双(二亚芐基丙酮)钯 | 32005-36-0 |
| Tetrakis(triphenylphosphine)palladium | 四(三苯基膦)钯 | 14221-01-3 |
联系方式
